DIN 02248624 — FASLODEX 250 MG
FASLODEX is a solution of Fulvestrant marketed by ASTRAZENECA CANADA INC. The full Fulvestrant monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02248624
- Brand name
- FASLODEX
- Active ingredient
- Fulvestrant
- Strength
- 250 MG
- Dosage form
- SOLUTION
- Route
- INTRAMUSCULAR
- Manufacturer
- ASTRAZENECA CANADA INC
- Health Canada status
- MARKETED
- Drug class
- Nonagonist estrogen receptor antagonist
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Fulvestrant products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02530635 | FULVESTRANT INJECTABLE | 250 MG | SOLUTION | JAMP PHARMA CORPORATION | MARKETED |
| 02483610 | FULVESTRANT INJECTION | 250 MG | SOLUTION | SANDOZ CANADA INCORPORATED | MARKETED |
| 02536293 | FULVESTRANT INJECTION | 250 MG | SOLUTION | FORMATIVE PHARMA INC. | MARKETED |
| 02558971 | FULVESTRANT INJECTION | 250 MG | SOLUTION | STERIMAX INC | MARKETED |
| 02460130 | TEVA-FULVESTRANT INJECTION | 250 MG | SOLUTION | TEVA CANADA LIMITED | MARKETED |